Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 3
Adagene announced its poster presentation at the SITC 38th Annual Meeting taking place November 1-5, 2023 in San Diego